Med24
Clinical Medicine 9. 10. 2026 • 2 min read • medical-news

Decades-Old Schizophrenia Drug Wins Approval for New Formulation

The FDA approved an easier-to-use once-monthly subcutaneous injectable form of olanzapine (Weltruza) for schizophrenia in adults, Teva Pharmaceuticals announced on Friday. A decades-old drug, olanzapine in its oral form is the...

Decades-Old Schizophrenia Drug Wins Approval for New Formulation

The FDA approved a new formulation of olanzapine for schizophrenia in adults. This subcutaneous injectable form is administered monthly. The new formulation eliminates the need for loading doses and post-injection delirium/sedation syndrome monitoring, addressing issues previously associated with other long-acting olanzapine products.

Sponsored content

Olanzapine has been a foundational treatment option for schizophrenia for over 30 years, but adherence remains a challenge. The new injectable formulation achieves therapeutic blood levels without oral cotreatment or booster injections. The approval was supported by the phase III SOLARIS trial, which demonstrated superiority over placebo in reducing PANSS total scores. Key secondary endpoints also showed improvement. No PDSS cases occurred during the trial. The new injectable is available in doses matching the approved oral olanzapine strengths. Like other antipsychotics, the product carries a boxed warning regarding increased mortality risk in elderly patients with dementia-related psychosis. Potential risks include metabolic changes, tardive dyskinesia, and orthostatic hypotension. Common adverse events observed in the SOLARIS trial were consistent with oral olanzapine, including increased weight, somnolence, headache, and constipation, alongside injection site reactions.”}

Original Scientific Source
medical-news
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Advertisement